Both in Pharmaceuticals
Annexon vs Geron
Over the past year ANNX returned +32.4% and GERN returned −5.3%; their daily moves had a correlation of 0.25.
ANNX +32.4% GERN −5.3%Growth of $1, one year, split-adjusted
| Metric | ANNX | GERN |
|---|---|---|
| Price | $4.13 | $1.24 |
| Market cap | $783.0M | $796.7M |
| Today | +2.99% | −0.80% |
| 1 month | −16.9% | −17.9% |
| 6 months | −16.7% | −12.1% |
| Year to date | −17.7% | −6.1% |
| 1 year | +22.6% | −3.9% |
| Revenue growth (YoY) | — | +17.2% |
| Gross margin | — | 83.9% |
| Net margin | — | −29.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.9× |
| Net cash | $209.2M | $51.1M |
| Dividend yield | — | — |
| Volatility (60d) | 68.8% | 66.5% |
| Short % of float | 21.4% | 13.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).